|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | |
| A61K 31/155 | |||
| A61K 31/505 | |||
| A61K 31/455 | |||
| A61K 31/616 | |||
| A61K 9/20 | |||
| A61K 9/16 | |||
| A61K 9/50 |
| (11) | Number of the document | 2709592 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12722820.3 |
| Date of filing the European patent application | 2012-05-17 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2012/051105 |
| Date | 2012-05-17 |
| (87) | Number | WO 2012/160352 |
| Date | 2012-11-29 |
| (30) | Number | Date | Country code |
| 201161488222 P | 2011-05-20 | US | |
| 201161577165 P | 2011-12-19 | US |
| (72) |
CREEKMORE, Joseph, Richard, US
KOTHARI, Sanjeev, Hukmichand, US
MUELLER, Bradford J., US
PENG, Yingxu, US
|
| (73) |
AstraZeneca UK Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA,
GB
|
| (54) | PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN CALCIUM |
| PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN CALCIUM |